Purpose
to provide continued support to determine whether the V3 loop of gp120 can induce broadly reactive, cross-neutralizing antibodies that will protect against infection with HIV-1
Grantee
Division
Global Health
Date
NOVEMBER 2009
Region served
AFRICA,
AMERICA,
ASIA
Committed amount
$1,447,040
Grant topic
HIV
Duration (months)
34
Grantee location
New York, New York, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.